Delivery Order SPE2DR25D1202-SPE2DR26F73HL
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,762.71 for Vivitrol 380 mg vial-diluents on August 14, 2025. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 15, 2025 and serves the Defense Logistics Agency's Medical Supply Chain. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $9,413.20 by the Defense Logistics Agency for VIVITROL 380 mg vials with diluents. The award is structured as a firm fixed price delivery order with an ultimate completion date of July 1, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,151.06 by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025, for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and performance to be completed in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,116.03 for Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,312.64 by the Defense Logistics Agency (DLA) on June 24, 2025, with an ultimate completion date of June 25, 2025. The award is for the supply of Vivitrol 380 mg vials with diluents, a medication used in addiction treatment and pain management. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.18 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $8,149.00 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract, issued September 8, 2025, with a completion date of September 9, 2025, represents a firm fixed-price award with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price, non-set-aside delivery order with a ceiling value of $12,857.90 and an ultimate completion date of May 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73HLDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $23,303.74 by the Defense Logistics Agency (DLA) for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, non-competitive delivery order with a completion date of December 22, 2025, and represents a child contract issued under a larger contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. Vivitrol is an extended-release naltrexone formulation used in medication-assisted treatment for opioid and alcohol use disorders, making this a critical pharmaceutical for military and federal healthcare systems. AmerisourceBergen serves as a primary pharmaceutical vendor to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs, with a demonstrated track record of competitively winning contracts across diverse therapeutic domains including specialty medications, vaccines, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 12/18/25 |